The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups

Michael T Jaklitsch, Francine L Jacobson, John H M Austin, John K Field, James R Jett, Shaf Keshavjee, Heber MacMahon, James L Mulshine, Reginald F Munden, Ravi Salgia, Gary M Strauss, Scott J Swanson, William D Travis, David J Sugarbaker, Michael T Jaklitsch, Francine L Jacobson, John H M Austin, John K Field, James R Jett, Shaf Keshavjee, Heber MacMahon, James L Mulshine, Reginald F Munden, Ravi Salgia, Gary M Strauss, Scott J Swanson, William D Travis, David J Sugarbaker

Abstract

Objective: Lung cancer is the leading cause of cancer death in North America. Low-dose computed tomography screening can reduce lung cancer-specific mortality by 20%.

Method: The American Association for Thoracic Surgery created a multispecialty task force to create screening guidelines for groups at high risk of developing lung cancer and survivors of previous lung cancer.

Results: The American Association for Thoracic Surgery guidelines call for annual lung cancer screening with low-dose computed tomography screening for North Americans from age 55 to 79 years with a 30 pack-year history of smoking. Long-term lung cancer survivors should have annual low-dose computed tomography to detect second primary lung cancer until the age of 79 years. Annual low-dose computed tomography lung cancer screening should be offered starting at age 50 years with a 20 pack-year history if there is an additional cumulative risk of developing lung cancer of 5% or greater over the following 5 years. Lung cancer screening requires participation by a subspecialty-qualified team. The American Association for Thoracic Surgery will continue engagement with other specialty societies to refine future screening guidelines.

Conclusions: The American Association for Thoracic Surgery provides specific guidelines for lung cancer screening in North America.

Copyright © 2012. Published by Mosby, Inc.

Source: PubMed

3
購読する